Tobin Scientific, a leading provider of cGMP storage, biorepository services, and specialized logistics for the life sciences industry, announced today that it has closed a significant capital raise to support its next phase of growth. Denali Growth Partners and Truck 9 Partners led the minority growth equity investment, and Eastern Bank provided a comprehensive financing package to support Tobin Scientific’s growth plans. The funding will be used to expand Tobin Scientific’s cGMP-compliant storage and logistics capacity, broaden its geographic footprint in key pharmaceutical hubs, and support targeted M&A initiatives across the broader life sciences supply chain. There has been no change of control, and the executive management team remains in place.
Tobin Scientific is widely recognized for its white-glove approach to biopharma logistics, including cold chain transport, compliant storage solutions, and end-to-end project execution for laboratories, manufacturing sites, and biorepositories across the U.S. With more than 365,000 square feet of cold chain and ambient warehouse space and a robust portfolio of specialized transportation and storage services, Tobin Scientific will continue to invest in advanced technologies and infrastructure to support its customers’ evolving needs.
“This capital raise marks a major milestone for our team and organization,” said Brian Tobin, CEO of Tobin Scientific. “We’re building critical infrastructure to support our clients at every stage of the R&D and manufacturing lifecycle from discovery through commercialization. Our partners share that vision, and this investment enables us to continue scaling with confidence and purpose. This investment is a testament to the dedication and expertise of our growing team and their commitment to the highest standards of service.”
“We are pleased to provide this credit facility to support Tobin Scientific’s strategic growth initiatives,” said Gregory Buscone, Executive Vice President, Chief Commercial Banking Officer at Eastern Bank. “Tobin Scientific’s commitment to expanding critical infrastructure and specialized pharma services plays a vital role. We are proud to help enable their vision of meeting the evolving needs of their customers in the Boston area and nationwide.”
“We are proud to invest in Tobin Scientific’s continued growth. The company’s strong track record and strategic vision highlight its commitment to becoming the leading vertically integrated services provider to the pharmaceutical industry, with innovative, forward-thinking solutions,” said Jesse Lane, the Founder and Managing Partner of Denali Growth Partners. “Tobin Scientific’s ability to drive sustained revenue growth is a direct result of its unwavering focus on meeting customer needs with consistency, reliability, and white-glove service,” added Alec Douglas of Denali Growth Partners.
Tom Babich, Managing Director of Stifel Financial Corp., served as the exclusive financial advisor to Tobin Scientific. Terms of the transaction were not disclosed.
